Heidi Fiegl
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (10)
Year:
2023
Year:
2023
Year:
2022
The mitochondrial enzyme fumarylacetoacetate hydrolase domain‐containing protein 1 (FAHD1) was identified to be upregulated in breast cancer tissues. Here, we show that FAHD1 is indispensable for the survival of BT‐20 cells, representing the basal breast cancer cell type. A lentiviral knock‐down of FAHD1 in the breast cancer cell lines MCF‐7 and BT‐20 results in lower succinate dehydrogenase (complex II) activity. In luminal MCF‐7 cells, this leads to reduced proliferation when cultured in medium containing only glutamine as the carbon source. Of note, both cell lines show attenuated protein levels of the enzyme glutaminase (GLS) which activates programmed cell death in BT‐20. These findings demonstrate that FAHD1 is crucial for the functionality of complex II in breast cancer cells and acts on glutaminolysis in the mitochondria.
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2020
Collaborators (11)
Judith Hagenbuchner
Head 3D Bioprinting Lab
Medical University of Innsbruck
Nicole Heinzl
Medical University of Vienna
Kerry Chester
University College London
Elisabeth Maria Damisch
Medical University of Innsbruck
Gareth J. Thomas
University of Southampton
Stephen Henderson
University College London
Alexander Weiss
European Research Institute for the Biology of Ageing, University of Groningen, UMC Groningen: Groningen, Netherlands
Andreas Villunger
Medical University of Innsbruck
Ian Reddin
University of Southampton
Hubert Hackl
Assistant Professor
Medical University of Innsbruck
Pidder Jansen‐Duerr
-
Make your next move.
Prepare your application
Review drafts before you send them.